All lobbying filings

Putalastrategies

Putalastrategies filed a Q4 report for Partner Therapeutics on January 18, 2026, reporting $60,000 in lobbying income.

Lobbying for Partner Therapeutics · Biopharmaceutical company

As filed: PUTALASTRATEGIES for PARTNER THERAPEUTICS.

All filings by Putalastrategies · Everything Partner Therapeutics has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 18, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 1

SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to medical treatments for radiation exposure, cancer, and COVID-19.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.